SlowBull
The Business Brief SATURDAY, 8 AUGUST 2026
← All stories
Markets

Congo Ebola Outbreak: Merck Ervebo Vaccine, Gilead Remdesivir Eyed for Wider Use

1 source ·1 article ·23h ago

Merck & Co.’s Ebola vaccine and an antiviral drug from Gilead Sciences Inc. are set for wider use in eastern Democratic Republic of Congo to blunt the fastest-growing Ebola outbreak on record.

Covered by 1 outlet

Bloomberg 1

All coverage · 1 article

Bloomberg Politics ·23h ago

Congo Ebola Outbreak: Merck Ervebo Vaccine, Gilead Remdesivir Eyed for Wider Use

Merck & Co.’s Ebola vaccine and an antiviral drug from Gilead Sciences Inc. are set for wider use in eastern Democratic Republic of Congo to blunt the fastest-growing Ebola outbreak on record.